Factory making Tetra-O-acetyl-β-D-ribofuranose - 2,4,5-Trifluorophenylacetic Acid CAS 209995-38-0 Purity ≥99.5% (GC) Sitagliptin Phosphate Monohydrate Intermediate – Ruifu
Factory making Tetra-O-acetyl-β-D-ribofuranose - 2,4,5-Trifluorophenylacetic Acid CAS 209995-38-0 Purity ≥99.5% (GC) Sitagliptin Phosphate Monohydrate Intermediate – Ruifu Detail:
Supply Sitagliptin Phosphate Monohydrate Related Intermediates:
Sitagliptin API CAS 486460-32-6
Sitagliptin Phosphate Monohydrate API CAS 654671-77-9
2,4,5-Trifluorophenylacetic Acid CAS 209995-38-0
Boc-(R)-3-Amino-4-(2,4,5-Trifluoro-Phenyl)-Butyric Acid CAS 486460-00-8
Sitagliptin Triazole Hydrochloride CAS 762240-92-6
Sitagliptin Phosphate Monohydrate Intermediate CAS 486460-21-3
Chemical Name | 2,4,5-Trifluorophenylacetic Acid |
CAS Number | 209995-38-0 |
CAT Number | RF-PI1191 |
Stock Status | In Stock, Production Scale Up to Tons |
Molecular Formula | C8H5F3O2 |
Molecular Weight | 190.12 |
Melting Point | 121.0 to 125.0℃ |
Solubility | Soluble in Methanol |
Brand | Ruifu Chemical |
Item | Specifications |
Appearance | White to Off-White Powder |
Purity / Analysis Method | ≥99.5% (GC) |
Moisture (K.F) | ≤0.50% |
Residue on Igniton | ≤0.50% |
Total Impurities | ≤0.50% |
Test Standard | Enterprise Standard |
Usage | Intermediate of Sitagliptin Phosphate Monohydrate (CAS: 654671-77-9) |
Package: Bottle, Aluminium foil bag, 25kg/Cardboard Drum, or according to customer’s requirement.
Storage Condition: Store in sealed containers at cool and dry place; Protect from light and moisture.
2,4,5-Trifluorophenylacetic Acid (CAS: 209995-38-0) is an intermediate of Sitagliptin Phosphate Monohydrate (CAS: 654671-77-9). Sitagliptin Phosphate (STG) is used to treat DM type 2 because it improves glycemic control by increasing the levels of active incretin hormones, GLP-1 (peptide-1) and GIP (glucose-dependent insulinotropic peptide). The activation of these incretins in β-pancreatic cells causes increased levels of cyclic adenosine monophosphate (cAMP) and intracellular calcium, with subsequent glucose-dependent insulin secretion (2). This hypoglycemic drug belongs to a new class called dipeptidyl peptidase IV inhibitors. STG was approved by the FDA in 2006.
Product detail pictures:
Related Product Guide:
owing to very good support, a variety of high quality merchandise, aggressive costs and efficient delivery, we love an excellent name among the our clients. We are an energetic company with wide market for Factory making Tetra-O-acetyl-β-D-ribofuranose - 2,4,5-Trifluorophenylacetic Acid CAS 209995-38-0 Purity ≥99.5% (GC) Sitagliptin Phosphate Monohydrate Intermediate – Ruifu , The product will supply to all over the world, such as: Salt Lake City, Tanzania, Italy, Our company always concentrate on the development of the international market. We have a lot of customers in Russia , European countries, the USA, the Middle East countries and Africa countries. We always follow that quality is foundation while service is guarantee to meet all customers.
By Lorraine from Hanover - 2018.07.12 12:19
This company has a lot of ready-made options to choose and also could custom new program according to our demand, which is very nice to meet our needs.
By Alice from Ottawa - 2018.09.08 17:09